• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. Achieving crystal-induced room temperature phosphorescence and reversible photochromic properties by strong intermolecular interactions?
  Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
• 4. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

Introduction to 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine (CAS No. 885267-38-9)

5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine (CAS No. 885267-38-9) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrimidines, which are essential building blocks in various biological processes and have been widely explored for their potential therapeutic applications. The unique combination of a bromo substituent, a methoxy group, and a piperazine moiety endows this compound with a diverse range of biological activities, making it a valuable candidate for drug development.

The chemical structure of 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine is characterized by its pyrimidine core, which is a six-membered heterocyclic ring containing two nitrogen atoms. The presence of the bromo substituent at the 5-position and the methoxy group at the 4-position imparts specific electronic and steric properties to the molecule. Additionally, the piperazine moiety at the 2-position introduces a flexible and polar group that can engage in various interactions with biological targets, enhancing its pharmacological profile.

Recent studies have highlighted the potential of 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine in various therapeutic areas. One notable application is its use as an inhibitor of specific kinases, which are key enzymes involved in cell signaling pathways. Kinase inhibitors have become an important class of drugs for treating cancers and other diseases characterized by aberrant cell signaling. Research has shown that 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine can selectively inhibit certain kinases, thereby disrupting the signaling pathways that drive disease progression.

In addition to its kinase inhibitory properties, 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine has also been investigated for its anti-inflammatory effects. Inflammation is a complex biological response that plays a crucial role in many diseases, including autoimmune disorders and chronic inflammatory conditions. Studies have demonstrated that this compound can modulate the expression of pro-inflammatory cytokines and other mediators, suggesting its potential as an anti-inflammatory agent.

The pharmacokinetic properties of 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine have also been extensively studied. Its solubility, stability, and bioavailability are important factors that influence its effectiveness as a therapeutic agent. Research has shown that this compound exhibits favorable pharmacokinetic profiles, making it suitable for further development as a drug candidate. However, ongoing studies are necessary to optimize these properties and ensure optimal therapeutic outcomes.

The safety profile of 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine is another critical aspect of its evaluation. Preclinical studies have demonstrated that this compound is generally well-tolerated at therapeutic doses, with minimal adverse effects observed in animal models. However, comprehensive safety assessments are essential to ensure its safe use in humans. Clinical trials are currently underway to evaluate the safety and efficacy of this compound in various disease settings.

In conclusion, 5-bromo-4-methoxy-2-(piperazin-1-yl)pyrimidine (CAS No. 885267-38-9) is a promising compound with a wide range of potential therapeutic applications. Its unique chemical structure and diverse biological activities make it an attractive candidate for further research and development. Ongoing studies continue to uncover new insights into its mechanisms of action and potential clinical uses, paving the way for innovative treatments in medicine.

• 871365-06-9(4,6-dimethoxy-2-(4-methyl-1-piperazinyl)-Pyrimidine)
• 885952-24-9(4-Benzyloxy-5-bromo-2-(4-methyl-1-piperazinyl)pyrimidine)
• 1193389-74-0(4-Methoxy-2-(piperazin-1-yl)pyrimidine dihydrochloride)
• 57054-84-9(2-Pyrimidinamine, 5-bromo-4-methoxy-N,N-dimethyl-)
• 106615-46-7(Pyrimidine,4,6-dimethoxy-2-(1-piperazinyl)-)
• 1448870-02-7(Ethanol, 2-[(5-bromo-4-methoxy-2-pyrimidinyl)amino]-)
• 1448870-03-8(5-bromo-4-methoxy-N-methyl-2-Pyrimidinamine)
• 1448870-01-6(Ethanol, 2-[(5-bromo-4-methoxy-2-pyrimidinyl)methylamino]-)
• 55745-88-5(4-Methoxy-2-piperazin-1-ylpyrimidine Dihydrochloride)
• 59549-50-7(Pyrimidine, 5-bromo-4-methoxy-2-(1-piperidinyl)-)